Literature DB >> 7514450

Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium.

M J Welsh1, A E Smith, J Zabner, D P Rich, S M Graham, R J Gregory, B M Pratt, R A Moscicki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7514450     DOI： 10.1089/hum.1994.5.2-209

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  12 in total

1.  Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo.

Authors:  C Hofmann; P Löser; G Cichon; W Arnold; G W Both; M Strauss
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 2.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

3.  Directed evolution of adeno-associated virus to an infectious respiratory virus.

Authors:  Katherine J D A Excoffon; James T Koerber; David D Dickey; Matthew Murtha; Shaf Keshavjee; Brian K Kaspar; Joseph Zabner; David V Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

4.  Antigenic homogeneity among the adenovirus hexon types of subgenus C.

Authors:  E Adám; I Nász; A Lengyel
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 5.  Gene therapy for cystic fibrosis: challenges and future directions.

Authors:  J M Wilson
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 6.  Respiratory medicine.

Authors:  R M du Bois
Journal:  BMJ       Date:  1995-06-17

Review 7.  Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF.

Authors:  Marie E Egan
Journal:  Pediatr Pulmonol       Date:  2021-02

Review 8.  Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.

Authors:  T M Clay; M C Custer; P J Spiess; M I Nishimura
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

9.  The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.

Authors:  T E Sparer; R A Tripp; D L Dillehay; T W Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Inflammation in cystic fibrosis.

Authors: 
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.